Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina
- Autores
- Bertot, Gustavo
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Fil: Bertot, Gustavo. Instituto Universitario de Ciencias de la Salud. Fundación Barceló; Argentina..
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has been increasing constantly and linked to the global obesity epidemic. The NAFLD histologic spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the only reliable means to diagnose and stage NASH, but its invasive nature limits its use. Therefore, the prediction of hepatic injury by means of the development of new noninvasive tests represents a growing medical need. Our aim was to evaluate matrix deposition and cell-death markers, which correlate with liver injury in an NAFLD patient cohort. - Materia
-
ARTICULO
METABOLISMO
HIGADO GRASO - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- Repositorio
- Institución
- Fundación H. A. Barceló
- OAI Identificador
- oai:fbarcelo:snrd:HASH01206b55572e1e6592587e17
Ver los metadatos del registro completo
id |
RIBARCELO_09a111a92af1475b1b3badea49da79da |
---|---|
oai_identifier_str |
oai:fbarcelo:snrd:HASH01206b55572e1e6592587e17 |
network_acronym_str |
RIBARCELO |
repository_id_str |
a |
network_name_str |
Repositorio Institucional (Fundacion Barceló) |
spelling |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from ArgentinaBertot, GustavoARTICULOMETABOLISMOHIGADO GRASOFil: Bertot, Gustavo. Instituto Universitario de Ciencias de la Salud. Fundación Barceló; Argentina..Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has been increasing constantly and linked to the global obesity epidemic. The NAFLD histologic spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the only reliable means to diagnose and stage NASH, but its invasive nature limits its use. Therefore, the prediction of hepatic injury by means of the development of new noninvasive tests represents a growing medical need. Our aim was to evaluate matrix deposition and cell-death markers, which correlate with liver injury in an NAFLD patient cohort.European Journal of Gastroenterology & Hepatology 2018. 30(6)2020-02-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://repositorio.barcelo.edu.ar/greenstone/collect/snrd/index/assoc/HASH0120.dir/BRC_76_MED_BA.pdfenginfo:eu-repo/semantics/openAccessreponame:Repositorio Institucional (Fundacion Barceló)instname:Fundación H. A. Barceló2025-09-18T10:48:55Zoai:fbarcelo:snrd:HASH01206b55572e1e6592587e17instacron:BARCELOInstitucionalhttp://repositorio.barcelo.edu.ar/greenstone/cgi-bin/library.cgiUniversidad privadaNo correspondehttp://repositorio.barcelo.edu.ar/greenstone/cgi-bin/oaiserver.cgilrodriguezares@barcelo.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:a2025-09-18 10:48:56.108Repositorio Institucional (Fundacion Barceló) - Fundación H. A. Barcelófalse |
dc.title.none.fl_str_mv |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
title |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
spellingShingle |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina Bertot, Gustavo ARTICULO METABOLISMO HIGADO GRASO |
title_short |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
title_full |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
title_fullStr |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
title_full_unstemmed |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
title_sort |
Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina |
dc.creator.none.fl_str_mv |
Bertot, Gustavo |
author |
Bertot, Gustavo |
author_facet |
Bertot, Gustavo |
author_role |
author |
dc.subject.none.fl_str_mv |
ARTICULO METABOLISMO HIGADO GRASO |
topic |
ARTICULO METABOLISMO HIGADO GRASO |
dc.description.none.fl_txt_mv |
Fil: Bertot, Gustavo. Instituto Universitario de Ciencias de la Salud. Fundación Barceló; Argentina.. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease whose prevalence has been increasing constantly and linked to the global obesity epidemic. The NAFLD histologic spectrum ranges from simple steatosis to nonalcoholic steatohepatitis (NASH), which can progress to cirrhosis and hepatocellular carcinoma. Liver biopsy is the only reliable means to diagnose and stage NASH, but its invasive nature limits its use. Therefore, the prediction of hepatic injury by means of the development of new noninvasive tests represents a growing medical need. Our aim was to evaluate matrix deposition and cell-death markers, which correlate with liver injury in an NAFLD patient cohort. |
description |
Fil: Bertot, Gustavo. Instituto Universitario de Ciencias de la Salud. Fundación Barceló; Argentina.. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-02-27 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://repositorio.barcelo.edu.ar/greenstone/collect/snrd/index/assoc/HASH0120.dir/BRC_76_MED_BA.pdf |
url |
http://repositorio.barcelo.edu.ar/greenstone/collect/snrd/index/assoc/HASH0120.dir/BRC_76_MED_BA.pdf |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
European Journal of Gastroenterology & Hepatology 2018. 30(6) |
publisher.none.fl_str_mv |
European Journal of Gastroenterology & Hepatology 2018. 30(6) |
dc.source.none.fl_str_mv |
reponame:Repositorio Institucional (Fundacion Barceló) instname:Fundación H. A. Barceló |
reponame_str |
Repositorio Institucional (Fundacion Barceló) |
collection |
Repositorio Institucional (Fundacion Barceló) |
instname_str |
Fundación H. A. Barceló |
repository.name.fl_str_mv |
Repositorio Institucional (Fundacion Barceló) - Fundación H. A. Barceló |
repository.mail.fl_str_mv |
lrodriguezares@barcelo.edu.ar |
_version_ |
1843611758499987456 |
score |
13.070432 |